Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline vs Ertapenem in cIAI
NCT01265784Phase 2Completed
- Sponsor
- Tetraphase Therapeutics
- Start
- Jan 2011
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of eravacycline in Intra-abdominal infection (IAI) (3 arms), sponsored by Tetraphase Therapeutics. Primary endpoint: Clinical Response to TP-434 and Ertapenem in the Microbiologically Evaluable (ME) Population. Started Jan 2011; status: completed.
02
Drugs
eravacycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT01265784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265784.